Short-term withdrawal from imiglucerase: what can we learn from it?
Hollak
Carla E M
CE
Academic Medical Centre, F5-170, PO box 22660, 1100 DD Amsterdam, The Netherlands. c.e.hollak@amc.uva.nl
D056947:Enzyme Replacement Therapy; D005776:Gaucher Disease / Q000188:drug therapy*; D005962:Glucosylceramidase / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D010347:Patient Care Planning; D013997:Time Factors
D005962:Glucosylceramidase; C090568:imiglucerase